VEXT SCIENCE INC - $VEXTF STOCK NEWS

Welcome to our dedicated page for VEXT SCIENCE news (Ticker: $VEXTF), a resource for investors and traders seeking the latest updates and insights on VEXT SCIENCE stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VEXT SCIENCE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VEXT SCIENCE's position in the market.

04/24/2024 06:55 PM

News

Vext Announces Delay of Annual Filings and Postponement of Conference Call

Rhea-AI Summary

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) announces a delay in the filing of its annual financial statements for 2023, related management discussions, and officer certifications. The delay is due to a recent auditor change and complex accounting treatment of Q4 2023 transactions. The company has postponed its conference call scheduled for April 25, 2024, until the filings are complete. Vext is actively working with auditors to complete the filings by May 10, 2024, and has applied for a management cease trade order to restrict trading until filings are submitted.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-5.82%

Tags

04/15/2024 07:30 AM

News

Vext to Announce Financial Results for Q4 and Fiscal 2023 on April 25, 2024

Rhea-AI Summary

Vext Science, Inc. (VEXTF) to announce financial results for Q4 and Fiscal 2023 on April 25, 2024. The U.S.-based cannabis operator with operations in Arizona and Ohio will host a conference call to discuss the results.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-5.62%

Tags

04/08/2024 07:30 AM

News

Vext Strengthens Ohio Presence with Dispensary Property Acquisition

Rhea-AI Summary

Vext Science, Inc. completes the acquisition of real property associated with a cannabis dispensary in Athens, Ohio as part of the Ohio Expansion Transaction. The Company paid $2.6 million for the acquisition, with $0.9 million in cash and a $1.7 million promissory note at 7.0% interest repayable over 10 years. The acquisition is expected to be completed by the end of 2024.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.9%

Tags

03/08/2024 05:30 PM

News

Vext Announces Change of Auditor

Rhea-AI Summary

Vext Science, Inc. changes its auditor from BF Borgers CPA PC to Reliant CPA due to enforcement actions by the Canadian Public Accountability Board. The Former Auditor resigned, and the Successor Auditor was appointed effective March 8, 2024.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2.23%

Tags

03/06/2024 05:00 PM

News

Vext Announces Closing of Debt Conversion Transaction

Rhea-AI Summary

Vext Science, Inc. receives regulatory approval and closes debenture conversion transaction. Insider shareholder Sopica Special Opportunities Fund Limited acquires 24,087,500 common shares.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

2.37%

Tags

03/01/2024 06:30 AM

News

Vext Completes Acquisition of Columbus Dispensary, Strengthens Vertically Integrated Position in Ohio

Rhea-AI Summary

Vext Science, Inc. completes the acquisition of a cannabis dispensary in Columbus, Ohio, positioning itself for growth in the $4 billion Ohio market. The company pays approximately $3 million for the Columbus Dispensary, enhancing its vertical operations in the state.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.41%

Tags

01/30/2024 05:00 PM

News

Vext Engages Zuanic & Associates

Rhea-AI Summary

Vext Science, Inc. has entered into an agreement with Zuanic & Associates to participate in US cannabis industry panels, aiming to raise public awareness of the company. The initial term of the agreement is six months.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.71%

Tags

01/16/2024 06:53 PM

News

Vext Announces Transition of Jason Thai Nguyen out of Executive Role

Rhea-AI Summary

Vext Science, Inc. announces the transition of Jason Thai Nguyen from his executive positions with the company while remaining on the board of directors. The settlement agreement details the extended payment period for Mr. Nguyen's cash severance amount. Additionally, an amendment to the promissory note, and a shareholders agreement with certain management shareholders and other shareholders of the company has been made.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2.99%

Tags

12/15/2023 04:30 PM

News

Vext Announces Voting Results of Annual General Meeting and Strengthens Board

Rhea-AI Summary

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) announced the addition of Terry L. Creighton and Spiro A. Phanos to its Board of Directors. Shareholders voted in favor of all matters at the annual general meeting, with each resolution passing with over 96% of the votes cast. The new directors bring leadership capabilities, operating experience, and deep expertise from the pharmaceutical and financial sectors.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

11/28/2023 06:30 AM

News

Vext Reports Financial Results for Q3 2023

Rhea-AI Summary

Vext Science, Inc. (VEXT) reported Q3 2023 revenue of $8.1 million, marking the 14th consecutive quarter of positive EBITDA and positive Adjusted EBITDA. The company generated $6.5 million in cash from the sale of its Prescott Valley cultivation facility and completed a private placement for net proceeds of $11.5 million. Vext also announced agreements to acquire two retail dispensaries in Ohio, positioning the company for growth in the adult-use market expected in 2024.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-3.1%

Tags